Intranasal Oligonucleotide Delivery: Nanopharm & Aptar Pharma Data

Nanopharm and Aptar Pharma present new data at IPAC-RS NIF 2026 proving Antisense Oligonucleotide (ASO) biologics can be nasally delivered intact